| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/08/2002 | CA2019622C Substituted arylamines and heteroarylamines, their preparation process and pharmaceutical composition containing them |
| 01/03/2002 | WO2002000614A1 Aryl compounds, their preparation and their use in therapy |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2002000574A2 Catalysis using phosphine oxide and sulfoxide compounds |
| 01/03/2002 | WO2000050470A3 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 01/03/2002 | US20020002192 For example, 3-benzyl-3-trichloroacetamido-1-(N-phenylamino-carbonyl)-N-(3-(2 -morpholinoethoxy)-phenyl)amino)methylcyclo-hexene; irritable bowel movement; esophageal reflux; counter-acting Erytromycin side effects |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | CA2740931A1 Catalysis using phosphine oxide and sulfoxide compounds |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 01/02/2002 | EP1167348A1 Nitrile derivatives |
| 01/02/2002 | EP1167342A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1167341A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165534A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/02/2002 | EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165504A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 01/02/2002 | EP1165502A1 Diaryl derivatives and their use as medicaments |
| 01/02/2002 | EP1165501A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165497A1 Method of preparing granular n-alkyl-ammonium acetonitrile salts |
| 01/02/2002 | EP1165495A1 Resorcinol derivatives |
| 01/02/2002 | EP1165494A2 Hsv primase inhibitors |
| 01/02/2002 | EP1165487A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP0873308B1 O-carbamoyl-phenylalaninol compounds and their pharmaceutically useful salts |
| 01/02/2002 | CN1328999A Piperazine dithioformates compounds, their preparation method and application in cancer-resisting medicine |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/02/2002 | CN1076949C Crop protective products |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 01/01/2002 | US6335444 Amino alcohol derivative and method for preparing the same |
| 01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
| 01/01/2002 | US6335333 Matrix metalloproteinase inhibitors |
| 01/01/2002 | US6335331 Antihistamines, antiallergens, brochodilator agents and antispasmodic agents |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 01/01/2002 | CA2010217C Aralkylamine compounds |
| 12/27/2001 | WO2001098303A1 Novel process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098284A1 Process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098279A2 Bis-arylsulfones |
| 12/27/2001 | WO2001098275A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098253A2 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinicreceptor antagonists |
| 12/27/2001 | WO2001098251A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098250A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097808A1 Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus |
| 12/27/2001 | US20010056106 Substituted phenylamino(methylcyclobutene) derivatives are useful in treating gastrointestinal disorders associated with antagonizing the the motillin receptor |
| 12/27/2001 | US20010056099 Method of reducing morbidity and the risk of mortality |
| 12/27/2001 | CA2413299A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2410452A1 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/27/2001 | CA2410447A1 Bis-arylsulfones |
| 12/26/2001 | CN1328545A Hydrazine derivatives |
| 12/25/2001 | CA2061875C Purification of 6-aminocapronitrile |
| 12/21/2001 | CA2351129A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/21/2001 | CA2351125A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/20/2001 | WO2001096293A1 Vitamin d derivatives |
| 12/20/2001 | WO2001095883A1 Novel pharmaceutical formulation suitable for nebulisation |
| 12/20/2001 | WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | WO2000072834A9 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 12/20/2001 | US20010053774 Non-steroidal ligands for the estrogen receptor |
| 12/20/2001 | DE10027604A1 Solutions of lithium-pyrrolidine in mixture of tetrahydrofuran and hydrocarbon useful for organic chemical synthesis and as polymerization catalysts |
| 12/20/2001 | CA2411805A1 Serine protease inhibitors |
| 12/20/2001 | CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 12/19/2001 | EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists |
| 12/19/2001 | EP1163213A1 Hydroxamic and carboxylic acid derivatives |
| 12/19/2001 | EP1163209A1 Compounds and compositions for delivering active agents |
| 12/19/2001 | EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/19/2001 | EP0721449B1 Inhibitors of beta-amyloid protein production |
| 12/19/2001 | EP0720605B1 Aminocyclohexylesters and uses thereof |
| 12/19/2001 | CN1327468A Organic electroluminescent element |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1076345C 2,3-diaminopropionic acid derivatives |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331629 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands |
| 12/18/2001 | US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/13/2001 | WO2001094354A1 Solutions of lithium pyrrolidine in tetrahydrofuran (thf)/hydrocarbons |
| 12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 12/13/2001 | WO2001094300A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 12/13/2001 | WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 12/13/2001 | WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters |
| 12/13/2001 | US20010051747 Diastereomer complex of at least three compounds, at least one is a resolving agent in optically active form, and at least one is an enantiomer in optically active form; rapid separation |
| 12/13/2001 | US20010051729 Slurry of a sodium aluminum hydride, lithium or titanium containing additive and a Lewis base in solvent; non-pyrophoric; thermal stability |
| 12/13/2001 | US20010051719 Novel compounds |